Physician profile

Michael Lieb

Phila, PA

NPI 1770641581

$10,857.08

in general payments reported to CMS, 2019-2025

34 companies · $1,312 in 2025

The $1,312 reported for 2025 was more than what 91% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,604.98
Travel and Lodging$346.96

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $2,093.39 2019-2025
Gilead Sciences, INC. $1,647.64 2019-2025 Livdelzi, Epclusa
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $1,308.85 2019-2025 Xifaxan, Relistor, Trulance
Janssen Biotech, INC. $786.15 2021-2025 Tremfya, Stelara, Simponi
Genzyme Corporation $595.63 2022-2025
Redhill Biopharma INC. $583.14 2020-2024 Talicia, Movantik, Aemcolo
Ironwood Pharmaceuticals, INC $518.23 2019-2024 Linzess
Inari Medical, INC. $346.96 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Celgene Corporation $315.03 2021-2024 Zeposia
Takeda Pharmaceuticals U.S.A., INC. $291.48 2019-2022
Merck Sharp & Dohme LLC $283.11 2019-2022
Qol Medical, LLC $276.82 2019-2025 Sucraid
Pfizer INC. $228.91 2022-2025
Ardelyx, INC. $227.53 2022-2024 Ibsrela
Aimmune Therapeutics, INC. $220.26 2023-2025 Zenpep, Vowst
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Shockwave Medical, INC $163.96 2025
Nestle Healthcare Nutrition INC. $160.92 2020-2023
Braintree Laboratories, INC. $143.08 2020-2023 Sutab
Phathom Pharmaceuticals, INC. $97.73 2023-2025 Voquezna
Evoke Pharma, INC. $97.15 2021-2024 Gimoti
Lilly USA, LLC $88.85 2024 Omvoh
Intercept Pharmaceuticals, INC. $59.34 2020-2023 Ocaliva
Smith+Nephew, INC. $51.84 2019
Celltrion USA INC. $46.88 2024 Vegzelma
Axonics, INC. $34.50 2022
Alfasigma USA, INC. $33.18 2020
Madrigal Pharmaceuticals $28.27 2024 Resmetirom
Bard Peripheral Vascular, INC. $24.97 2019
Shionogi INC $22.12 2019
Exact Sciences Corporation $17.60 2025 Cologuard Collection Kit
Janssen Pharmaceuticals, INC $17.36 2019
Allergan, INC. $17.08 2020
Shire North American Group INC $16.03 2019
Mauna Kea Technologies, INC. $13.09 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Lieb

$10,857.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $1,312 reported for 2025 was more than what 91% of providers received nationally.

https://glasscript.com/doctor/352516/michael-lieb

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.